This study investigated the association between the use of aspirin after the diagnosis for colorectal cancer (CRC) and CRC-specific survival and overall survival. Researchers suggested that the use of aspirin after diagnosis is associated with a positive outcome.

This study investigated how oxaliplatin chemotherapy causes liver damage.

The authors provided insight into the mechanism of liver injury, and suggest that bevacizumab (Avastin) may protect against such injury.

This trial looked at the use of short-course radiotherapy (RT) followed by chemotherapy (CT) and delayed surgery to reduce distant metastases (tumor spread) in patients with locally advanced rectal cancer (LARC). The trial found that this treatment was more effective in controlling distant metastases when compared to standard chemoradiotherapy (CRT) followed by surgery and adjuvant CT (chemotherapy after surgery). 

This study investigated whether colorectal cancer survival rates were influenced by levels of vitamin D in the body.

This study evaluated whether surgery has an effect on aerobic performance in colorectal cancer patients. 

This trial looked at the length of adjuvant chemotherapy (AC; chemotherapy after surgery) for patients with stage III colon cancer. The authors found that 3 months of AC resulted in similar survival with reduced levels of toxicity, and cost compared to 6 months. 

This study examined the impact of higher calcium, vitamin D and dairy products on colorectal cancer survival.

The current study examined whether the proteins versican and lumican were predictive of prognosis among colon cancer patients.